You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 10, October 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Significant Metabolic Acidosis Induced by Acetazolamide

Not a Rare Complication

Israel Heller, MD; Jonathan Halevy, MD; Shimon Cohen, MD; Emanuel Theodor, MD

Arch Intern Med. 1985;145(10):1815-1817.


Abstract

• Blood gas and serum electrolyte levels were measured in 27 elderly patients (mean age ± SD, 63.3 ± 13.5 years) who were receiving acetazolamide (250 to 1,000 mg/day) for glaucoma. Eleven glaucomatous patients (mean age, 69.1 ± 7.4 years) who were not receiving acetazolamide served as a control group. In the acetazolamide-treated group, four patients (14.8%) had mild acidosis (7.29>pH≤7.31), ten (37%) had moderate acidosis (7.20>pH≤7.29), and one patient (3.7%) had severe acidosis (pH, 7.15). None of the patients in the control group had acidosis. It is concluded that moderate metabolic acidosis of potential clinical significance is common among glaucomatous elderly patients who receive acetazolamide. The exact clinical significance of our observations is yet to be determined.

(Arch Intern Med 1985;145:1815-1817)



Author Affiliations

From the Departments of Internal Medicine "E" (Drs Halevy and Theodor) and Ophthalmology (Drs Heller and Cohen), Beilinson Medical Center, Petah Tiqva, Israel, and Tel Aviv (Israel) University Sackler School of Medicine. Dr Halevy is now at Yale University School of Medicine, New Haven, Conn.


Footnotes

Accepted for publication Jan 2, 1985.

Reprint requests to Department of Internal Medicine "E," Beilinson Medical Center, Petah Tiqva 49100, Israel (Dr Halevy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Preretinal Neovascularization Associated with Acetazolamide-Induced Systemic Acidosis in the Neonatal Rat
Zhang et al.
IOVS 2001;42:1066-1071.
ABSTRACT | FULL TEXT  

Remodeling the cellular profile of collecting ducts by chronic carbonic anhydrase inhibition
Bagnis et al.
Am. J. Physiol. Renal Physiol. 2001;280:F437-F448.
ABSTRACT | FULL TEXT  

Medical Management of Glaucoma
Alward
NEJM 1998;339:1298-1307.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.